124292-70-2

Basic information

• Product Name: 1H-Pyrazole, 1,5-dimethyl-4-nitroso-3-phenyl-
• CAS NO: 124292-70-2
• Molecular Formula: C11H11N3O
• Molecular Weight: 201.228
• Mol File: 124292-70-2.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole, 1,5-dimethyl-4-nitroso-3-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole, 1,5-dimethyl-4-nitroso-3-phenyl-(124292-70-2)
• EPA Substance Registry System: 1H-Pyrazole, 1,5-dimethyl-4-nitroso-3-phenyl-(124292-70-2)

Safety Data

• Hazardous Substances Data: 124292-70-2(Hazardous Substances Data)

Upstream product

• 6797-44-0 2-oximino-1-penyl-1,3-butanedione 
• 60-34-4 methylhydrazine 

Downstream Products

• 124292-73-5 2-Chloro-N-(1,5-dimethyl-3-phenyl-1H-pyrazol-4-yl)-benzamide 
• 124292-80-4 N-phenyl-N'-(1,5-dimethyl-3-phenylpyrazol-4-yl) urea 
• 124292-72-4 N-(1,5-Dimethyl-3-phenyl-1H-pyrazol-4-yl)-benzamide 
• 124292-71-3 1,5-dimethyl-3-phenyl-1H-pyrazol-4-amine 

Relevant articles and documents

PYRAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which ca

N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.

N-BICYCLIC ARYL,N'-PYRAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.